BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25238755)

  • 1. The ap-2 clathrin adaptor mediates endocytosis of an inhibitory killer cell Ig-like receptor in human NK cells.
    Purdy AK; Alvarez Arias DA; Oshinsky J; James AM; Serebriiskii I; Campbell KS
    J Immunol; 2014 Nov; 193(9):4675-83. PubMed ID: 25238755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2004 Jun; 172(12):7385-92. PubMed ID: 15187115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402.
    Sharma D; Bastard K; Guethlein LA; Norman PJ; Yawata N; Yawata M; Pando M; Thananchai H; Dong T; Rowland-Jones S; Brodsky FM; Parham P
    J Immunol; 2009 Oct; 183(7):4569-82. PubMed ID: 19752231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1.
    Pando MJ; Gardiner CM; Gleimer M; McQueen KL; Parham P
    J Immunol; 2003 Dec; 171(12):6640-9. PubMed ID: 14662867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence.
    Campbell KS; Yusa S; Kikuchi-Maki A; Catina TL
    J Immunol; 2004 Jan; 172(2):899-906. PubMed ID: 14707061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase C regulates expression and function of inhibitory killer cell Ig-like receptors in NK cells.
    Alvarez-Arias DA; Campbell KS
    J Immunol; 2007 Oct; 179(8):5281-90. PubMed ID: 17911614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand.
    Carr WH; Pando MJ; Parham P
    J Immunol; 2005 Oct; 175(8):5222-9. PubMed ID: 16210627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies.
    Trundley A; Frebel H; Jones D; Chang C; Trowsdale J
    Eur J Immunol; 2007 Mar; 37(3):780-7. PubMed ID: 17301953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degenerate recognition of MHC class I molecules with Bw4 and Bw6 motifs by a killer cell Ig-like receptor 3DL expressed by macaque NK cells.
    Maloveste SM; Chen D; Gostick E; Vivian JP; Plishka RJ; Iyengar R; Kruthers RL; Buckler-White A; Brooks AG; Rossjohn J; Price DA; Lafont BA
    J Immunol; 2012 Nov; 189(9):4338-48. PubMed ID: 23041569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dyslexia-associated protein KIAA0319 interacts with adaptor protein 2 and follows the classical clathrin-mediated endocytosis pathway.
    Levecque C; Velayos-Baeza A; Holloway ZG; Monaco AP
    Am J Physiol Cell Physiol; 2009 Jul; 297(1):C160-8. PubMed ID: 19419997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analysis of the interaction between Dishevelled2 and clathrin AP-2 adaptor, a critical step in noncanonical Wnt signaling.
    Yu A; Xing Y; Harrison SC; Kirchhausen T
    Structure; 2010 Oct; 18(10):1311-20. PubMed ID: 20947020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational Changes in the Cytoplasmic Region of KIR3DL1 upon Interaction with SHP-2.
    Cheng H; Schwell V; Curtis BR; Fazlieva R; Roder H; Campbell KS
    Structure; 2019 Apr; 27(4):639-650.e2. PubMed ID: 30773397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palmitoylation of protease-activated receptor-1 regulates adaptor protein complex-2 and -3 interaction with tyrosine-based motifs and endocytic sorting.
    Canto I; Trejo J
    J Biol Chem; 2013 May; 288(22):15900-12. PubMed ID: 23580642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells.
    Yusa S; Campbell KS
    J Immunol; 2003 May; 170(9):4539-47. PubMed ID: 12707331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
    Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
    J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clathrin terminal domain-ligand interactions regulate sorting of mannose 6-phosphate receptors mediated by AP-1 and GGA adaptors.
    Stahlschmidt W; Robertson MJ; Robinson PJ; McCluskey A; Haucke V
    J Biol Chem; 2014 Feb; 289(8):4906-18. PubMed ID: 24407285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the receptor-binding function of clathrin adaptor protein AP-2 by dominant-negative mutant mu2 subunit and its effects on endocytosis.
    Nesterov A; Carter RE; Sorkina T; Gill GN; Sorkin A
    EMBO J; 1999 May; 18(9):2489-99. PubMed ID: 10228163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation.
    Zhao XY; Yu XX; Xu ZL; Cao XH; Huo MR; Zhao XS; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ
    Blood Adv; 2019 Dec; 3(24):4312-4325. PubMed ID: 31869417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.